pharma · Multiple Myeloma · Not applicable - Healthy volonteers · GPCR
Structure Therapeutics
Structure Therapeutics is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker GPCR. Primary therapeutic focus areas include Multiple Myeloma, Not applicable - Healthy volonteer
601 Gateway Blvd, Suite 900, South San Francisco, California 94080, US HQ
2017 Founded
202 Employees
Public company Type
GPCR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 601 Gateway Blvd, Suite 900, South San Francisco, California 94080, US
- Founded
- 2017
- Employees
- 202
- Programs
- 13
- Drugs
- 7
- Patents
- 93
TG-0054 (2.24 mg/kg)
Phase 2 · small molecule · Multiple Myeloma
TG-0054 (2.24 mg/kg) for Multiple Myeloma is a Phase 2 program (small_molecule) at Structure Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code TG-0054-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Structure Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Multiple Myeloma
- Status
- completed
- Trials
- 1